Biblio
.
Donor immunization against human leukocyte class II antigens is a risk factor for graft-versus-host disease. Biol Blood Marrow Transplant. 2015.
Mucormycosis: a new concern in the transplant ward?. Curr Opin Hematol. 2014;21(6):482-490.
.